• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单侧输尿管梗阻和转化生长因子-β1刺激后肾小管间质细胞中H3K9的表观遗传修饰

Epigenetic Modifications to H3K9 in Renal Tubulointerstitial Cells after Unilateral Ureteric Obstruction and TGF-β1 Stimulation.

作者信息

Hewitson Timothy D, Holt Stephen G, Tan Sven-Jean, Wigg Belinda, Samuel Chrishan S, Smith Edward R

机构信息

Department of Nephrology, The Royal Melbourne Hospital, MelbourneVIC, Australia.

Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, MelbourneVIC, Australia.

出版信息

Front Pharmacol. 2017 May 29;8:307. doi: 10.3389/fphar.2017.00307. eCollection 2017.

DOI:10.3389/fphar.2017.00307
PMID:28611663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5447091/
Abstract

Epigenetic regulation of fibrogenesis through post-translational histone modifications (marks) may be a key determinant of progression in renal disease. In this study, we examined the distribution and acquisition of histone 3 Lysine 9 (H3K9) marks after injury and stimulation with the pro-fibrotic cytokine TGF-β1. Our focus was on their presence in activated fibroblasts (myofibroblasts) and epithelial cells (epithelial-mesenchymal transition). Immunofluorescent microscopy was used to examine global H3K9 acetylation (H3K9Ac) and tri-methylation (H3K9Me3) after unilateral ureteric obstruction (UUO) in mice. Confocal, super resolution microscopy and flow cytometry were used to determine the effect of TGF-β1 on structural arrangement of these marks, and their relationship with α-smooth muscle actin (αSMA) expression, a marker of myofibroblasts and early EMT. The number of individual histone marks was increased 10 days after UUO ( < 0.05 vs. control), with both marks clearly seen in various cell types including proximal tubules and myofibroblasts. Sub-nuclear microscopy in primary rat renal fibroblasts and a proximal tubule cell line (NRK-52e) showed that H3K9Ac was co-localized with phosphorylated-Ser2 RNA polymerase II (pRNAPol II), while H3K9Me3 was not, consistent with permissive and repressive effects on gene expression respectively. In both cell types H3K9Ac was diffusely distributed throughout the nucleus, while H3K9Me3 was found in compartments resembling the nucleolus, and in the case of the fibroblast, also juxtapositioned with the nuclear membrane. TGF-β1 had no effect on H3K9Ac marks in either cell, but resulted in a redistribution of H3K9Me3 within the fibroblast nucleus. This was unrelated to any change in mitogenesis, but was associated with increased αSMA expression. These findings highlight why it is important to consider the epigenetics of each cell individually, because whilst no overall enrichment occurred, renal myofibroblast differentiation was accompanied by distinct changes in histone mark arrangements.

摘要

通过翻译后组蛋白修饰(标记)对纤维化形成的表观遗传调控可能是肾脏疾病进展的关键决定因素。在本研究中,我们检测了在用促纤维化细胞因子转化生长因子-β1(TGF-β1)损伤和刺激后组蛋白3赖氨酸9(H3K9)标记的分布和获得情况。我们重点关注它们在活化的成纤维细胞(肌成纤维细胞)和上皮细胞(上皮-间充质转化)中的存在情况。采用免疫荧光显微镜检测小鼠单侧输尿管梗阻(UUO)后整体H3K9乙酰化(H3K9Ac)和三甲基化(H3K9Me3)情况。使用共聚焦显微镜、超分辨率显微镜和流式细胞术来确定TGF-β1对这些标记结构排列的影响,以及它们与α-平滑肌肌动蛋白(αSMA)表达的关系,αSMA是肌成纤维细胞和早期上皮-间充质转化的标志物。UUO后10天,单个组蛋白标记的数量增加(与对照组相比,P<0.05),在包括近端小管和肌成纤维细胞在内的各种细胞类型中均清晰可见这两种标记。原代大鼠肾成纤维细胞和近端小管细胞系(NRK-52e)的亚核显微镜检查显示,H3K9Ac与磷酸化的丝氨酸2 RNA聚合酶II(pRNAPol II)共定位,而H3K9Me3则不然,这分别与对基因表达的允许和抑制作用一致。在这两种细胞类型中,H3K9Ac均弥漫分布于整个细胞核,而H3K9Me3则存在于类似核仁的区域,在成纤维细胞中,还与核膜并列。TGF-β1对两种细胞中的H3K9Ac标记均无影响,但导致成纤维细胞核内H3K9Me3重新分布。这与有丝分裂发生的任何变化无关,但与αSMA表达增加有关。这些发现凸显了单独考虑每个细胞的表观遗传学为何重要,因为虽然没有发生整体富集,但肾肌成纤维细胞分化伴随着组蛋白标记排列的明显变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95f3/5447091/507e3dbc3c28/fphar-08-00307-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95f3/5447091/05c99bf6488a/fphar-08-00307-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95f3/5447091/86506c18ba84/fphar-08-00307-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95f3/5447091/ecb1f32a0930/fphar-08-00307-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95f3/5447091/3830d328fc8c/fphar-08-00307-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95f3/5447091/f93c342ee07c/fphar-08-00307-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95f3/5447091/2b166e92ea07/fphar-08-00307-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95f3/5447091/ece48fd5007f/fphar-08-00307-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95f3/5447091/9ca83ddd1ba3/fphar-08-00307-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95f3/5447091/95d13f8cbb1b/fphar-08-00307-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95f3/5447091/507e3dbc3c28/fphar-08-00307-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95f3/5447091/05c99bf6488a/fphar-08-00307-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95f3/5447091/86506c18ba84/fphar-08-00307-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95f3/5447091/ecb1f32a0930/fphar-08-00307-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95f3/5447091/3830d328fc8c/fphar-08-00307-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95f3/5447091/f93c342ee07c/fphar-08-00307-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95f3/5447091/2b166e92ea07/fphar-08-00307-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95f3/5447091/ece48fd5007f/fphar-08-00307-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95f3/5447091/9ca83ddd1ba3/fphar-08-00307-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95f3/5447091/95d13f8cbb1b/fphar-08-00307-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95f3/5447091/507e3dbc3c28/fphar-08-00307-g010.jpg

相似文献

1
Epigenetic Modifications to H3K9 in Renal Tubulointerstitial Cells after Unilateral Ureteric Obstruction and TGF-β1 Stimulation.单侧输尿管梗阻和转化生长因子-β1刺激后肾小管间质细胞中H3K9的表观遗传修饰
Front Pharmacol. 2017 May 29;8:307. doi: 10.3389/fphar.2017.00307. eCollection 2017.
2
Inhibition of spleen tyrosine kinase (syk) suppresses renal fibrosis through anti-inflammatory effects and down regulation of the MAPK-p38 pathway.抑制脾酪氨酸激酶(syk)可通过抗炎作用和下调丝裂原活化蛋白激酶p38(MAPK-p38)信号通路来抑制肾纤维化。
Int J Biochem Cell Biol. 2016 May;74:135-44. doi: 10.1016/j.biocel.2016.03.001. Epub 2016 Mar 3.
3
The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.胰高血糖素样肽-1(GLP-1)类似物利拉鲁肽可减轻肾纤维化。
Pharmacol Res. 2018 May;131:102-111. doi: 10.1016/j.phrs.2018.03.004. Epub 2018 Mar 9.
4
Adenovirus-mediated P311 ameliorates renal fibrosis through inhibition of epithelial-mesenchymal transition via TGF-β1-Smad-ILK pathway in unilateral ureteral obstruction rats.腺病毒介导的 P311 通过 TGF-β1-Smad-ILK 通路抑制上皮间质转化改善单侧输尿管梗阻大鼠的肾纤维化。
Int J Mol Med. 2018 May;41(5):3015-3023. doi: 10.3892/ijmm.2018.3485. Epub 2018 Feb 12.
5
WISP3 prevents fibroblast-myofibroblast transdifferentiation in NRK-49F cells.WISP3 可防止 NRK-49F 细胞中的成纤维细胞-肌成纤维细胞转分化。
Biomed Pharmacother. 2018 Mar;99:306-312. doi: 10.1016/j.biopha.2018.01.005.
6
Profiling histone modifications in the normal mouse kidney and after unilateral ureteric obstruction.在正常小鼠肾脏和单侧输尿管梗阻后分析组蛋白修饰。
Am J Physiol Renal Physiol. 2019 Sep 1;317(3):F606-F615. doi: 10.1152/ajprenal.00262.2019. Epub 2019 Jul 3.
7
MAD2B promotes tubular epithelial-to-mesenchymal transition and renal tubulointerstitial fibrosis via Skp2.MAD2B通过Skp2促进肾小管上皮-间充质转化和肾小管间质纤维化。
J Mol Med (Berl). 2016 Nov;94(11):1297-1307. doi: 10.1007/s00109-016-1448-6. Epub 2016 Aug 3.
8
Let-7d miRNA prevents TGF-β1-induced EMT and renal fibrogenesis through regulation of HMGA2 expression.Let-7d微小RNA通过调控HMGA2的表达来预防转化生长因子-β1诱导的上皮-间质转化和肾纤维化。
Biochem Biophys Res Commun. 2016 Oct 28;479(4):676-682. doi: 10.1016/j.bbrc.2016.09.154. Epub 2016 Sep 29.
9
Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis.在子宫腺肌病的发展过程中,血小板诱导的上皮间质转化和成纤维细胞向肌成纤维细胞转分化的佐证证据。
Hum Reprod. 2016 Apr;31(4):734-49. doi: 10.1093/humrep/dew018. Epub 2016 Feb 22.
10
[Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1].[抑制素抑制转化生长因子-β1诱导的肾间质成纤维细胞增殖和表型改变]
Zhonghua Yi Xue Za Zhi. 2007 Jun 26;87(24):1660-5.

引用本文的文献

1
Histone methylation of kidney disease: fact or fantasy?肾脏疾病中的组蛋白甲基化:事实还是幻想?
Ren Fail. 2025 Dec;47(1):2538801. doi: 10.1080/0886022X.2025.2538801. Epub 2025 Sep 10.
2
Epigenetic memories induced by hypoxia in AKI-to-CKD transition.急性肾损伤向慢性肾病转变过程中由缺氧诱导的表观遗传记忆。
Clin Exp Nephrol. 2025 Aug 20. doi: 10.1007/s10157-025-02745-1.
3
Acute kidney injury through a metabolic lens: pathological reprogramming mechanisms and clinical translation potential.从代谢角度看急性肾损伤:病理重编程机制及临床转化潜力

本文引用的文献

1
FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts.FGF23 由肾脏小管局部合成,并激活损伤激活的成纤维细胞。
Sci Rep. 2017 Jun 13;7(1):3345. doi: 10.1038/s41598-017-02709-w.
2
Estrogens do not protect, but androgens exacerbate, collagen accumulation in the female mouse kidney after ureteric obstruction.雌激素不能保护,而雄激素加剧雌性小鼠输尿管梗阻后肾脏胶原的积累。
Life Sci. 2016 Aug 1;158:130-6. doi: 10.1016/j.lfs.2016.06.022. Epub 2016 Jun 29.
3
The molecular hallmarks of epigenetic control.表观遗传控制的分子特征。
Front Physiol. 2025 Jun 6;16:1602865. doi: 10.3389/fphys.2025.1602865. eCollection 2025.
4
Epigenetic therapeutics attenuate kidney injury and fibrosis by restoring the expression of epigenetically reprogrammed fibrogenic genes and signaling pathways.表观遗传学疗法通过恢复表观遗传重编程的纤维化基因和信号通路的表达来减轻肾损伤和纤维化。
Eur J Pharm Sci. 2025 Jan 1;204:106977. doi: 10.1016/j.ejps.2024.106977. Epub 2024 Nov 29.
5
Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review).组蛋白甲基化修饰与糖尿病肾病:潜在的分子机制和治疗方法(综述)。
Int J Mol Med. 2024 Nov;54(5). doi: 10.3892/ijmm.2024.5428. Epub 2024 Sep 20.
6
Epigenetic mechanisms differentially regulate blood pressure and renal dysfunction in male and female Npr1 haplotype mice.表观遗传机制在雄性和雌性 Npr1 单倍型小鼠中差异调节血压和肾功能障碍。
FASEB J. 2024 Aug 15;38(15):e23858. doi: 10.1096/fj.202400714R.
7
Sex-specific modulation of renal epigenetic and injury markers in aging kidney.衰老肾脏中性别特异性的肾表观遗传和损伤标志物的调节
Am J Physiol Renal Physiol. 2024 Sep 1;327(3):F543-F551. doi: 10.1152/ajprenal.00140.2024. Epub 2024 Jul 4.
8
Histone H3K18 and Ezrin Lactylation Promote Renal Dysfunction in Sepsis-Associated Acute Kidney Injury.组蛋白 H3K18 和 Ezrin 乳酰化促进脓毒症相关急性肾损伤的肾功能障碍。
Adv Sci (Weinh). 2024 Jul;11(28):e2307216. doi: 10.1002/advs.202307216. Epub 2024 May 20.
9
Sex-specific epigenetic programming in renal fibrosis and inflammation.性别特异性的肾纤维化和炎症中的表观遗传编程。
Am J Physiol Renal Physiol. 2023 Nov 1;325(5):F578-F594. doi: 10.1152/ajprenal.00091.2023. Epub 2023 Aug 10.
10
5-Aza-2'-Deoxycytidine (5-Aza-dC, Decitabine) Inhibits Collagen Type I and III Expression in TGF-β1-Treated Equine Endometrial Fibroblasts.5-氮杂-2'-脱氧胞苷(5-aza-dC,地西他滨)抑制转化生长因子-β1处理的马子宫内膜成纤维细胞中I型和III型胶原蛋白的表达。
Animals (Basel). 2023 Mar 30;13(7):1212. doi: 10.3390/ani13071212.
Nat Rev Genet. 2016 Aug;17(8):487-500. doi: 10.1038/nrg.2016.59. Epub 2016 Jun 27.
4
TGF-β: the master regulator of fibrosis.TGF-β:纤维化的主调控因子。
Nat Rev Nephrol. 2016 Jun;12(6):325-38. doi: 10.1038/nrneph.2016.48. Epub 2016 Apr 25.
5
MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis.微小RNA作为治疗肾损伤和纤维化的新型治疗靶点。
Am J Physiol Renal Physiol. 2016 May 1;310(10):F931-44. doi: 10.1152/ajprenal.00523.2015. Epub 2016 Feb 24.
6
Analysis of histone modifications at human ribosomal DNA in liver cancer cell.肝癌细胞中人类核糖体DNA的组蛋白修饰分析。
Sci Rep. 2015 Dec 11;5:18100. doi: 10.1038/srep18100.
7
Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression.抑制组蛋白 H3K9 甲基转移酶 G9a 可减轻肾脏纤维化并维持 klotho 的表达。
Kidney Int. 2016 Jan;89(1):147-57. doi: 10.1038/ki.2015.291. Epub 2016 Jan 4.
8
miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.微小RNA-21通过靶向磷酸酶和张力蛋白同源物(PTEN)及SMAD7促进糖尿病肾病中的肾纤维化。
Clin Sci (Lond). 2015 Dec;129(12):1237-49. doi: 10.1042/CS20150427. Epub 2015 Sep 28.
9
Inhibition of SET Domain-Containing Lysine Methyltransferase 7/9 Ameliorates Renal Fibrosis.抑制含SET结构域的赖氨酸甲基转移酶7/9可改善肾纤维化。
J Am Soc Nephrol. 2016 Jan;27(1):203-15. doi: 10.1681/ASN.2014090850. Epub 2015 Jun 4.
10
Recent developments in epigenetics of acute and chronic kidney diseases.急性和慢性肾脏疾病表观遗传学的最新进展。
Kidney Int. 2015 Aug;88(2):250-61. doi: 10.1038/ki.2015.148. Epub 2015 May 20.